Polar Capital Holdings PLC Arrowhead Pharmaceuticals, Inc. Transaction History

Polar Capital Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $137,335 - $223,916	-4,635 Reduced 26.98%	12,547 $415,000
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $161,199 - $228,965	2,775 Added 19.26%	17,182 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $260,491 - $379,091	4,462 Added 44.87%	14,407 $899,000
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $750,336 - $1.09 Million	-12,073 Reduced 54.83%	9,945 $824,000
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $1.35 Million - $1.99 Million	22,018 New	22,018 $1.46 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.